Results 71 to 80 of about 2,572,587 (193)

Successful use of acarbose to manage post-prandial glycaemia in two patients with type 1 diabetes on continuous subcutaneous insulin infusion

open access: yes, 2012
Post-prandial hyperglycaemia is a particular problem for some patients with diabetes despite administering continuous subcutaneous insulin infusion (CSII) to deliver insulin flexibly.
Hartnell, Sara J.   +13 more
core   +1 more source

Clinical Efficacy of Two Different Methods to Initiate Sensor-Augmented Insulin Pumps: A Randomized Controlled Trial

open access: yesJournal of Diabetes Research, 2016
Aim. To analyze clinical effect of a novel approach to initiate sensor-augmented insulin pumps in type 1 diabetes mellitus (T1DM) patients through early real-time continuous glucose monitoring (RT-CGM) initiation. Methods. A 26-week pilot study with T1DM
Jesus Moreno-Fernandez   +3 more
doaj   +1 more source

[Cost-effectiveness of continuous subcutaneous insulin infusion therapy for type 1 diabetes]

open access: yes, 2010
This study's aim was to project the long-term clinical and economic outcomes of continuous subcutaneous insulin infusion (CSII) treatment compared to multiple daily injections (MDI) in type 1 diabetes patients in ...
Sohlberg, Anna   +2 more
core  

Does continuous insulin therapy reduce postoperative supraventricular tachycardia incidence after coronary artery bypass operations in diabetic patients?

open access: yes, 2020
Objective: To compare continuous insulin infusion (CII) and intermittent subcutaneous insulin therapy for preventing supraventricular tachycardia.
KIRDEMİR, Pakize   +6 more
core   +1 more source

The education of patients in prandial insulin dosing related to the structure of bolus calculators [PDF]

open access: yesPediatric Endocrinology, Diabetes and Metabolism, 2010
The metabolic effect of insulin pump therapy depends on precise adjustments of insulin to food intake ratio. Calculation of prandial insulin dose is a complex process employing many variant factors such as pre-prandial glucose and carbohydrate (CHO ...
Marlena Błazik, Ewa Pańkowska
doaj  

‐I bioactivity than continuous subcutaneous insulin infusion

open access: yes, 2014
ObjectiveType 1 diabetes (T1D) is associated with low IGF-I and altered levels of IGF-binding proteins (IGFBPs) in plasma. This may be of importance for insulin sensitivity and the risk of developing diabetic complications.
Christina A. Hedman   +14 more
core   +1 more source

Treatment of unstable diabetes by continuous subcutaneous infusion of insulin.

open access: yes, 1981
In a group of seven brittle diabetic males, hospitalized, two kind of treatment has been compared: conventional insulin therapy (three daily injections) versus continuous subcutaneous insulin infusion.
CONSOLI, Agostino   +4 more
core  

Continuous Subcutaneous Insulin Infusion in Comparison to Subcutaneous Insulin Injections in the Preschooler with Type 1 Diabetes Mellitus

open access: yes, 2012
Type 1 Diabetes Mellitus is a form of diabetes that results from autoimmune destruction of insulin-producing beta cells of the pancreas subsequently causing a lack of insulin and leading to increased blood and urine glucose (Cihakova, 2001).
D\u27Agostino, Meredith
core   +1 more source

Circulating insulin antibodies: influence of continuous subcutaneous or intraperitoneal insulin infusion, and impact on glucose control.

open access: yes, 2009
peer reviewedThe purification of animal insulin preparations and the use of human recombinant insulin have markedly reduced the incidence, but not completely suppressed, the development of anti-insulin antibodies (IAs).
E. Renard   +8 more
core   +1 more source

Practical Aspects and Considerations When Switching Between Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections

open access: yes, 2010
Insulin pump therapy is considered the gold standard for insulin management in patients requiring full physiologic insulin replacement. Compared to traditional delivery of short- and long-acting insulin preparations by multiple daily insulin injections ...
Jane Sparrow-Bodenmiller   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy